Related Experiment Video

Updated: Mar 30, 2026

Live-cell Imaging of Lysosomal Membrane Permeabilization During Necroptosis
05:30

Live-cell Imaging of Lysosomal Membrane Permeabilization During Necroptosis

Published on: November 14, 2025

560

The oncolytic peptide LTX-315 triggers necrotic cell death

Sabrina Forveille1,2,3,4, Heng Zhou1,2,3,4,5, Allan Sauvat1,2,3,4

  • 1a Metabolomics and Cell Biology Platforms; Gustave Roussy Comprehensive Cancer Institute ; Villejuif , France.

Cell Cycle (Georgetown, Tex.)
|November 15, 2015
PubMed

Insights

The oncolytic peptide LTX-315 kills cancer cells by inducing unregulated necrosis, not apoptosis. This cell death mechanism may enhance its anti-cancer immune effects.

Area of Science:

  • Oncology
  • Immunology
  • Cell Biology

Background:

  • The oncolytic peptide LTX-315 is designed to kill cancer cells.
  • LTX-315 has demonstrated the ability to stimulate anti-cancer immune responses.
  • The precise mechanism of cell death induced by LTX-315 requires clarification.

Purpose of the Study:

  • To determine whether LTX-315 induces apoptosis or necrosis in cancer cells.
  • To investigate the role of caspases and regulated necrosis in LTX-315-mediated cell death.

Main Methods:

  • Transmission electron microscopy was used to analyze cell morphology.
  • Morphometric analysis of chromatin-stained tumor cells was performed.
  • Experiments involved assessing caspase-3 activation and the effects of specific inhibitors (Z-VAD-fmk, necrostatin-1, cyclosporin A).

Main Results:

  • LTX-315 did not induce apoptotic nuclear condensation, indicating it does not trigger apoptosis.
  • A necrotic phenotype was observed in LTX-315-treated cells.
  • LTX-315 did not activate caspase-3, and caspase inhibition did not affect cell killing.
  • Inhibitors of regulated necrosis (necroptosis) did not reduce LTX-315-induced cell death.

Conclusions:

  • LTX-315 appears to induce unregulated necrosis in cancer cells.
  • Unregulated necrosis may contribute to the observed pro-inflammatory and pro-immune effects of LTX-315.
  • Further research into the immunomodulatory role of necrosis induced by LTX-315 is warranted.
Keywords:
anticancer immunity, apoptotsis, necrosis, LTX-315

More Related Videos

Characterization of MLKL-mediated Plasma Membrane Rupture in Necroptosis08:55

Characterization of MLKL-mediated Plasma Membrane Rupture in Necroptosis

Published on: August 7, 2018

11.4K
Author Spotlight: THP-1 Macrophage Response to LPS/ATP — Unveiling the Pyroptosis, Apoptosis, and Necroptosis Spectrum06:12

Author Spotlight: THP-1 Macrophage Response to LPS/ATP — Unveiling the Pyroptosis, Apoptosis, and Necroptosis Spectrum

Published on: May 3, 2024

3.7K

Related Concept Videos

Necrosis01:16

Necrosis

Necrosis is considered as an “accidental” or unexpected form of cell death that ends in cell lysis. The first noticeable mention of “necrosis” was in 1859 when Rudolf Virchow used this term to describe advanced tissue breakdown in his compilation titled “Cell Pathology”.
Morphological Manifestations of Necrosis
Necrotic cells show different types of morphological appearance depending on the type of tissue and infection. In coagulative necrosis, cells become...
7.2K
The Extrinsic Apoptotic Pathway01:17

The Extrinsic Apoptotic Pathway

The extrinsic apoptotic pathway is initiated when extracellular death-inducing signals, such as specific cytokines, activate the death receptors expressed on the cell surface. The immune cells involved in this pathway are natural killer cells (NK cells) and cytotoxic T-lymphocytes. NK cells are critical in innate immune response, while cytotoxic T-lymphocytes are associated with adaptive immune response. These cells recognize specific receptors expressed on the altered cells and activate...
9.3K
Overview of Cell Death01:30

Overview of Cell Death

Cell death is an essential process where the body gets rid of old or damaged cells. Cell proliferation and death need to be balanced, as an imbalance between the two may lead to cancer or autoimmune diseases.
Cell death was observed in the early 19th century, but there was no experimental evidence to prove it. In 1842, Carl Vogt first discovered cell death in a metamorphic toad; however, it was not termed ‘cell death.’ Scientists discovered different cell death pathways only in the...
11.1K
Cytotoxic T Cells-mediated Immune Response01:27

Cytotoxic T Cells-mediated Immune Response

Cytotoxic T cells are a vital component of the immune system. They have the remarkable ability to identify and target antigens on infected or abnormal cells. These antigens often originate from intracellular pathogens such as viruses or abnormal proteins cancer cells produce.
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
8.2K
Tumor Immunotherapy01:27

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
2.2K
Autophagic Cell Death01:18

Autophagic Cell Death

Christian de Duve discovered “autophagy,” a process in which cellular components are engulfed by membrane-bound organelles called autophagosomes. The autophagosomes then fuse with lysosomes to digest the enclosed contents. Autophagy is generally activated in cells to prevent cell death. However, cell death is triggered when the damage is beyond repair.
Autophagy and Apoptosis
Autophagy can activate apoptosis. In normal conditions, the autophagy activating protein Beclin-1 and...
5.0K